Riskpilot← Back to searchSign inGet full accessNefelibata AB
ABActiveOrg 5590602719Stärteredsvägen 12General medical practice activities · NACE 8621Est. 20162 employees
Revenue 2026
SEK 2M
0% vs 2025
EBITDA margin
46.6%
+15% vs 2025
Equity ratio
79.0%
Financial strength
Net profit 2026
SEK 711K
+15% vs 2025
| Revenue | SEK 2M | +0% |
| EBITDA | SEK 909K | +15% |
| Net profit | SEK 711K | +15% |
| Total assets | SEK 1,1M | +3% |
| Equity | SEK 830K | +24% |
| Employees | 2 | — |
Legal name
Nefelibata AB
Org number
5590602719
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
23 april 2016
Share capital
SEK 50 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2026-02-28
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget ska bedriva privat läkarverksamhet samt konsult- och föreläsningsverksamhet inom hälsa och sjukvård ävensom idka därmed förenlig verksamhet. Bolaget ska även bedriva inspelning, produktion samt marknadsföring av musik, video, film och media samt därmed förenlig verksamhet.
Address
Stärteredsvägen 12
Email
nefelibata.ab@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Revenue | 149 | 1 128 | 1 893 | 1 958 | 1 952 |
| Staff expenses | — | −389 | −1 217 | −1 125 | −1 159 |
| EBITDA | 115 | 692 | 640 | 791 | 909 |
| Depreciation & amort. | −2 | −12 | −12 | −12 | −12 |
| EBIT | 113 | 681 | 628 | 779 | 897 |
| Net financials | — | 0 | 3 | 1 | −1 |
| Profit before tax | 113 | 681 | 632 | 780 | 897 |
| Tax | −17 | −139 | −130 | −161 | −186 |
| Net profit | 96 | 542 | 502 | 619 | 711 |
| Item | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Total assets | 163 | 1 061 | 1 337 | 1 017 | 1 051 |
| Equity | 122 | 600 | 552 | 669 | 830 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 40 | 461 | 784 | 348 | 221 |
| Total debt | 40 | 461 | 784 | 348 | 221 |
EBITDA margin
46.6%
This company
15.8%
Market median
+195% vs market
20222026
Equity ratio
79.0%
This company
38.2%
Market median
+107% vs market
20222026
Return on equity
85.6%
This company
18.4%
Market median
+365% vs market
20222026
Net profit margin
36.4%
This company
8.1%
Market median
+349% vs market
20222026
Asset turnover
1.86×
This company
1.12×
Market median
+66% vs market
20222026
Debt / equity
0.27×
This company
0.62×
Market median
+56% vs market
20222026
- Annual report 2026Filed via Bolagsverket / SCB · Period 2025-03-01 – 2026-02-28
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-03-01 – 2025-02-28
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-03-01 – 2024-02-29
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-03-01 – 2023-02-28
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-03-01 – 2022-02-28
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2022 | |
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Nefelibata AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Hotan Mojdehi | Chairman | 0 companies |
| Tania Ebtedai | Board of Directors | 0 companies |
| Mahmoud Mojdehi | Deputy Board Member | 0 companies |